Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Clitocybin A from a mushroom may promote hair growth by increasing cell activity in hair follicles.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Carbamazepine may cause reversible nail detachment.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Urtica dioica L. extract may help treat tinea corporis but is less effective than terbinafine.

Dab2 protein is crucial for hair follicle stem cell renewal and preventing early aging.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Clitocybin A can promote hair growth by increasing cell proliferation.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Insulin helps heal corneal wounds and nerves in diabetic mice by activating the Wnt signaling pathway.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

The hydrogel dressing speeds up and improves diabetic wound healing.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Vitamin C derivative may promote hair growth by activating specific genes.